Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
07/2005
07/13/2005EP1551418A1 Substituted ketophosphonate compounds having bone anabolic activity
07/13/2005EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
07/13/2005CN1639344A A method of selectively producing male or female sterile plants
07/13/2005CN1639177A Novel phosoxophite ligands and use thereof in carbonylation processes
07/13/2005CN1639176A Phosphonites, use thereof as ligand in transition metal complexes and method for production of nitriles
07/13/2005CN1639175A Novel phosphonamides, process for producing the same, and use thereof
07/13/2005CN1639174A Oligomeric, hydroxy-terminated phosphonates
07/13/2005CN1639135A N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
07/13/2005CN1639110A Haloacetamide and azide substituted compounds and methods of use thereof
07/13/2005CN1638168A Quadribasic phthalocyanine copper film with controllably doped tetrachlorobenzoquinone/triphenyl phosphorus and its prepn process
07/13/2005CN1637008A High metathesis activity ruthenium and osmium metal carbene complexes
07/13/2005CN1636971A Oxime derivatives and the use thereof as latent acids
07/13/2005CN1210284C Bisphenol-A bis (diphenyl phosphate)-based flame retardant
07/13/2005CN1210283C Process for making glyphosate by oxidizing N-substituted glyphosates
07/13/2005CN1210280C Integrated process for preparation of diene complexes
07/13/2005CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders
07/13/2005CN1209964C Pesticide formulations containing phosphate ester surfactant and alkoxylated lignosulfonate
07/12/2005US6916944 Bismuth compound, process of producing the same, and process of producing a film
07/12/2005US6916937 For ishcemia/stroke therapy; calcium-activated potassium channel modulators
07/12/2005US6916835 Nitrate esters and their use for neurological conditions
07/12/2005US6916797 α-arylethylpiperazine derivatives as neurokinin antagonists
07/12/2005US6916460 Macrocyclic chelants for metallopharmaceuticals
07/07/2005WO2005061501A2 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
07/07/2005WO2005061416A1 Method for isolating acids from chemical reaction mixtures by using 1-alkylimidazoles
07/07/2005WO2005060647A2 Prodrugs of selective androgen receptor modulators and methods of use thereof
07/07/2005WO2005060500A2 Process for manufacture of pentaerythritol diphosphites
07/07/2005WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
07/07/2005WO2005007603A3 Fluorocombretastatin and derivatives thereof
07/07/2005WO2005005447A3 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
07/07/2005US20050150013 Generating sex specific sterility in plants via vector transformation and expression of phytotoxic converting enzymes; hybrid seed production and enhanced crop yields
07/07/2005US20050149164 Method for treating neurovascular aneurysms
07/07/2005US20050148675 Efficient and inexpensive method to prepare ubiquinone precursors using benzenoid precursor with retention of the double bond stereochemistry; industrial scale; carbolumination of alkynes
07/07/2005US20050148644 Ligands for Inosine-5'-monophosphate dehydrogenase; antiviral, antiinflammatory, antibiotics, transplant rejection, autoimmune disease, , antipsoriatic immunosuppressants; 3-uriedo benzyl carbamate derivatives; high potency, side effects reduction; bioavailability; antivascular hyperproliferative
07/07/2005US20050148623 HIV protease inhibiting compounds
07/07/2005US20050148548 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
07/07/2005US20050148531 Antisense agents; blocking agents (biotin); high throughput screening
07/07/2005US20050148517 Carotenoid ether analogs or derivatives for controlling connexin 43 expression
07/07/2005US20050148042 Hybrid phosphoinositide phospholipids: compositions and uses
07/07/2005US20050148032 Chemoselective ligation
07/07/2005US20050147843 carbazole phenylpyridine metal complexes or conjugated with additional polymers, for use in a light-emitting device; light emission from triplet excited state
07/07/2005DE10356822A1 Verfahren zur Abtrennung von Pb und Ni aus Co-haltigen Gemischen Process for the separation of Pb and Ni of Co-containing mixtures
07/07/2005CA2548088A1 Process for manufacture of pentaerythritol diphosphites
07/07/2005CA2547159A1 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
07/07/2005CA2522874A1 Prodrugs of selective androgen receptor modulators and methods of use thereof
07/06/2005EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
07/06/2005EP1549387A1 Antisense modulation of farnesoid x receptor expression
07/06/2005EP1549322A2 Lipid a and other carbohydrate ligand analogs
07/06/2005EP1060264B1 Dideoxy dye terminators
07/06/2005CN1636004A Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
07/06/2005CN1635994A Process for preparation of carotenoids
07/06/2005CN1634943A Acyclic nucleotide analogs, method for synthesis and antiviral application
07/06/2005CN1634942A Stabilized silver sulfonate complex of organo-phosphine, method for synthesizing and use thereof
07/06/2005CN1634941A Process for one-pot preparation of chloromethyl monosodium phosphonate
07/06/2005CN1634940A Mixed bed ion exchange resin method for purifying lecithin and cephalin
07/06/2005CN1634939A Supercritical CO2 extraction process for soya bean lecithin
07/06/2005CN1634938A Process for preparing alkyl phosphate
07/05/2005US6914161 Process to prepare a multidentate phosphine compound
07/05/2005US6914148 Monomer for use in huaman therapeutics and diagnostics
07/05/2005US6914056 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
07/05/2005US6913897 Comprises dioxetane compound and phosphatases
07/05/2005CA2253545C Phosphatidic acid-comprising compositions
07/05/2005CA2199679C Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients
07/05/2005CA2093946C Methanediphosphonic acid formulations with ion exchangers
06/2005
06/30/2005WO2005058926A1 New process for preparing diisopropyl ((1-((2-amino-6-chloro-9h-purin-9-yl)methyl)cyclopropyl)oxy)methylphosphonate
06/30/2005WO2005058925A1 New process for preparing diisopropyl ((1-((2-amino-6-halo-9h-purin-9-yl)methyl)cyclopropyl)oxy)methylphosphonate
06/30/2005WO2005058924A1 Method for producing phosphonium salts
06/30/2005WO2005058923A1 Organophosphorous indazole derivatives and use thereof as protein kinase inhibitors
06/30/2005WO2005058917A2 New oxazoline ligands for asymmetric catalysis
06/30/2005WO2005058916A2 Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins
06/30/2005WO2005058888A2 Oxazolidinone-quinolone hybrid antibiotics
06/30/2005WO2005058886A1 Novel oxazolidinone derivatives
06/30/2005WO2005058877A1 Novel chelating agents and highly luminescent and stable chelates and their use
06/30/2005WO2005058805A1 Process for producing optically active amine compound
06/30/2005WO2005058789A2 Copper (i) formate complexes
06/30/2005WO2005058788A1 Process of preparing glycolaldehyde
06/30/2005WO2005058330A1 Phosphorus containing compounds useful for the regulation of ldl and lp(a) levels
06/30/2005WO2005058250A2 Methods of administering water-soluble prodrugs of propofol for extended sedation
06/30/2005WO2005040357A3 Compounds and methods for fluorescent labeling
06/30/2005WO2005040178A9 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex
06/30/2005WO2004100960A8 Anti-inflammatory phosphonate compounds
06/30/2005WO2004096236A3 Immunomodulator phosphonate conjugates
06/30/2005WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
06/30/2005US20050143475 Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
06/30/2005US20050143455 such as (4-methyl-trans-cyclohexane-1,2-diamine)-oxalatoplatinum
06/30/2005US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases
06/30/2005US20050143418 Pesticidal heterocycles
06/30/2005US20050143349 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels
06/30/2005US20050142542 Absobers materials used for removal or reduction of microbiocides from body fluids such as blood; filtration
06/30/2005US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
06/30/2005US20050139822 A series of aromatic rings carrying a linear alkylene chain substituted with a polar group, e.g., 5-ethyl-5'''-(10-undecenyl)-2,2':5',2'':5'',2'''-quaterthiophene; thin films having the function of a dielectric layer and of a semiconductive layer; a self-assembled molecule (SAMS); low surface voltage
06/30/2005CA2550074A1 Novel chelating agents and highly luminescent and stable chelates and their use
06/30/2005CA2549456A1 Process of preparing glycolaldehyde
06/30/2005CA2548216A1 Methods of administering water-soluble prodrugs of propofol for extended sedation
06/30/2005CA2546903A1 Organophosphorous indazole derivatives and use thereof as protein kinase inhibitors
06/30/2005CA2546480A1 Method for producing phosphonium salts
06/29/2005EP1548021A1 One-part self-etching, self-priming dental adhesive composition
06/29/2005EP1547603A2 Compositions and methods for use in targeting vascular destruction
06/29/2005EP1546164A1 (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof
06/29/2005EP1546163A1 Method for the production of acylphosphine oxides
06/29/2005EP1546162A2 Luminescence-based methods and probes for measuring cytochrome p450 activity